Latest Therapeutic Goods Administration News | Page 2

Medicinal cannabis has gone mainstream. But Australia’s struggling to cope
TGA Product Information Safety Updates 23 March
What does One Nation actually believe in?
View New National Clinical Governance Committee for Digital Health drives collaboration and clinical safety
Women’s health is not a pilot project”: RACGP on Government decision to prioritise political donations over safety
National Disruption Group nets millions with major multi-state success
New project to expand pioneering cellular immunotherapy technology to India
More than 650 gather for AusBiotech and Medicines Australia Women in Life Sciences Luncheon & Leadership Summit
TGA ignored as Victorian Government ‘shortcut’ puts women at risk: RACGP
Peptides And Social Media
GMP Annex 6 and Annex 15 concept papers – Open for public consultation
Update To Listed Medicine Ingredients In March 2026
TGA Product Information Safety Updates 25 February
New Resources On Market Actions And Minor PRAC Updates
Bernard Lane exposes regulator “flying blind” on puberty blockers – ban the child gender experiment now
What are the current guidelines for early prostate cancer detection in Australia?
New Documentary: Prescription for Violence – Psychiatry’s Deadly Side Effects: TGA Issues Homicidal Ideation Warning for ADHD Drug
Medicines Containing Vitamin B6
TGA Product Information Safety Updates 17 February
AusBiotech and Medicines Australia expand Women in Life Sciences partnership
RACGP calls on SA Government to ensure evidence-based approach to primary care reforms
Schools Ready For New Anaphylaxis Treatments For Students
Vape enforcement crackdown with major seizure in Burwood NSW
Clinicians and pharmacists – Are your patients aware of the risks of buying melatonin online?
Prime Medic Group issued infringement notices for alleged unlawful advertising of weight loss medicines
AusBiotech reiterates calls for a national whole-of-government approach to life sciences as global peers accelerate government-industry collaboration
Upgrade of TGA’s internal database for medicine adverse events reports
TGA issues infringement notices to 6 individuals for alleged importation and unlawful advertising of therapeutic goods
Nitrosamine Impurities Acceptable Intakes Update 29 January
TGA seizes illegal vapes in Inverloch Victoria following alleged sales to young people
Listed medicines using indications related to diarrhoea requiring a warning statement
TGA Statement On Sunscreen Labelling Practices
The TGA releases compliance principles, reinforcing proactive and risk-based enforcement throughout 2026 and 2027
Conviction for unlawful supply and advertising of black salve products
TGA Product Information Safety Updates 15 January
Booty N Buff Nutrition issued infringement notices for the alleged unlawful advertising of sports supplements
Long-acting HIV PrEP registration brings us another step closer to ending HIV for Australia, but access remains a barrier
Proposed amendments relating to transparency of disruptions to supply of a medical device
TGA approves registration of lenancapavir for pre-exposure prophylaxis (PreP) for HIV (YEYTUO)
What you need to know about why it’s important to keep wearing sunscreen
Worried after sunscreen recalls? Here’s how to choose a safe one
New responsibilities for ACT Nurse Practitioners in Australian first
Taking a drug like Ozempic? What you need to know about risks of suicidal thoughts and contraception failure
Australian Summer Rituals: Sunscreen, Surf and Skin Checks
Vitamin B6 products are set to be restricted. Here’s what you need to know
Reaffirming Safety Of Australia’s Vaccines
Foreign Investment Decision
Vertex Receives TGA Approval for ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class CFTR Modulator for the Treatment of Cystic Fibrosis